The prevalence of one of the most common cardiovascular conditions in the U.S. is significantly higher than previously estimated, underscoring the need for better prevention and treatment strategies.
Read MoreAdipo Therapeutics, LLC, a late pre-clinical biopharmaceutical company developing treatments for obesity and related metabolic disorders, announced the positive results for a key study demonstrating promising results using human tissue samples.
Read MoreThe U.S. Food and Drug Administration approved Eli Lilly and Company’s Zepbound injection, the first and only obesity treatment of its kind that activates both glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 hormone receptors.
Read MoreObesity and overweight are estimated to have caused a staggering $9.3 billion reduction in Indiana’s economy in 2022, equivalent to 2% of the state’s gross domestic product, according to a report released by GlobalData Plc, a leading data and analytics company based in London.
Read MoreBy MARY ANN LIENHART CROSS County Extension Director, Extension Educator – Health & Human Sciences, Purdue Extension Elkhart County What is your favorite beverage? What beverages do you drink at home, at work, and when eating away from home? I was pleased to hear recently that pop consumption is down … Read More
INDIANA — The 12th Annual State of Obesity report reveals large regional and racial differences when it comes to obesity in America.
Read More
